Good work Trendy. I still find it interesting that the mention of presenting Flucide to a "Major Pharma" and that they expressed an interest in moving forward with it (I listened again, almost an exact quote) did not get a PR. I would think he must be referring to the MTA for EKC-cide that was PRed, and perhaps along with that the pharma said they would also take a look at Flu-cide. Otherwise it makes no sense. Maybe it was a combo deal but the Pharma only wanted the EKC-cide mentioned. ???
Anyway, nice work. [By the way - you got published on AllAllan]